Medicare Panel Supports Use of Provenge in FDA-Approved Population


Published On: November 18th, 2010

The advisory panel’s average confidence score (on a scale of 1 to 5) was 3.6 for evidence of an overall survival benefit.

View original here: 
Medicare Panel Supports Use of Provenge in FDA-Approved Population



Loading...


Comments are closed.